Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.4%

62 terminated/withdrawn out of 1158 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

11%

130 trials in Phase 3/4

Results Transparency

12%

83 of 685 completed trials have results

Key Signals

124 recruiting83 with results47 terminated15 withdrawn

Enrollment Performance

Analytics

N/A
392(46.9%)
Phase 1
192(23.0%)
Phase 2
105(12.6%)
Phase 4
71(8.5%)
Phase 3
59(7.1%)
Early Phase 1
17(2.0%)
836Total
N/A(392)
Phase 1(192)
Phase 2(105)
Phase 4(71)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1158)

Showing 20 of 1158 trials
NCT05648448Phase 2Recruiting

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Role: lead

NCT06282718Recruiting

A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe

Role: collaborator

NCT06815081Recruiting

Capillary OGTT Study

Role: lead

NCT06320535Phase 1Active Not Recruiting

A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

Role: lead

NCT05571735Recruiting

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Role: lead

NCT06845618Recruiting

Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

Role: lead

NCT07506421Not ApplicableRecruiting

Hope Groups: Parenting and Mental Health Among Refugees in the Middle East

Role: lead

NCT06670378Active Not Recruiting

Natural History Study for Patients With Nemaline Myopathy in the UK

Role: lead

NCT06563921Not ApplicableNot Yet Recruiting

RE and Probiotics in MAFLD/NAFLD

Role: collaborator

NCT05155579Phase 1Completed

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Role: lead

NCT07460401Not Yet Recruiting

'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Physiotherapy-led Rehabilitation'

Role: lead

NCT07192393Recruiting

Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).

Role: collaborator

NCT07494786Not ApplicableRecruiting

Palestinian ParentText for Crisis

Role: lead

NCT07257965Not ApplicableRecruiting

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

Role: lead

NCT06687694Recruiting

Immune Mechanisms of Antipsychotic Treatment Response

Role: collaborator

NCT05380388Phase 2Not Yet Recruiting

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Role: lead

NCT05385042Not ApplicableCompleted

Iron and Immune Response to Vaccine (IRONMUM)

Role: lead

NCT07267559Phase 4Recruiting

Dual Orexin Antagonism and Emotion and Affective Processing Study

Role: lead

NCT05994742Phase 3Active Not Recruiting

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Role: collaborator

NCT07481435Not Yet Recruiting

TRacheostomy in DElphi for iNTensive Care' (TRiDENT)

Role: collaborator